NFKB1 and colorectal carcinoma: The validation of in-vivo models aligned with the findings of in-vitro models, supporting the exploration of YGS’s inhibition of tumor immune escape through NF-κB pathway sensitization in CRC stem cells, and its capability to suppress the EMT process in CRC at the tissue level.